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Abstract To evaluate the relationship among quality of
life, temperament, illness perception, and mental turmoil in
patients affected by chronic daily headache with concom-
itant medication overuse headache. Participants were 116
consecutive adult outpatients admitted to the Department
of General Medicine of the Sant’Andrea Hospital in Rome,
between January 2007 and December 2007 with a diag-
nosis of chronic daily headache (illness duration[5 years).
Patients were administered the Temperament Evaluation of
Memphis, Pisa, Paris and San Diego-autoquestionnaire
version (TEMPS-A), the Beck Hopelessness Scale (BHS),
the Hamilton Rating Scale for Depression (HAM-D), the
Mini-International Neuropsychiatric Interview (MINI), the
Revised Illness Perception Questionnaire (IPQ), the
Suicide Score Scale (SSS), and the Quality of Life Index
(QL-Index). Twenty-eight percent of the patients evi-
denced moderate to severe depression, and 35% evidenced
severe hopelessness. Analyses also indicated that quality of
life, temperament, illness perception, and psychological
turmoil are associated. However, a hierarchical multivari-
ate regression analysis with quality of life as dependent
variable indicated that only a model with mental turmoil
variables may fit data; further, only the MINI suicidal
intent resulted associated with quality of life (standardized
regression coefficient = -0.55; t = -3.06; P \ 0.01).
Suicide risk may play a central role in affecting the quality
of life of patients with chronic headache. The investigation
of the interplay of factors that precipitate suicide risk
should include assessment of chronic headache and its
effects on wellbeing.
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Introduction
The International Classification of Headache Disorders, II
version (ICHD-II) recognises 24 types of chronic headache
and defines primary episodic headaches as chronic when the
attacks appear for more than 15 days/month and for at least
3 months [1]. The influence of psychological factors in the
pathogenesis, clinical course and treatment of primary
headache has always been of interest and is highly relevant
for both research and clinical practice [2], especially since
psychological and behavioural states seem particularly
important in promoting its transformation into chronic daily
headache (CDH), which often sustains drug abuse [3].
Migraine may be combined with drug overuse, first
labelled by ICDH-II in 2004 (and revised in 2005) as med-
ication overuse headache (MOH), when it is associated with
overuse of a combination of analgesics, barbiturates,
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opioids, Ergot alkaloids, aspirin, FANS, caffeine and trip-
tans. MOH has been the subject of increasing research
attention in recent years. A negative impact of this type of
headache has been detected on the quality of life (including
professional, social and emotional aspects) and on psychi-
atric comorbidity [4]. Boes and Capobianco [5] documented
the crucial role of depression in the process of transformation
of migraine into MOH. Similar results were obtained by
Radat et al. [6] in a retrospective comparative study carried
out on 41 patients with migraine and 41 patients with MOH
(treated with one or more of the following drugs, alone or in
combination: paracetamol, codeine, tryptans, non-steroidal
anti-inflammatory drugs [NSAID], salicylates, and ergot
derivatives). They found a higher prevalence of anxiety and
mood disorders in patients with MOH (as assessed through
the DSM-IV MINI interview) during the phase of transfor-
mation of migraine into MOH. A study by De Filippis et al.
[7] showed that patients with chronic daily headache and
those with MOH both show high levels of anxiety and
depressive symptoms associated with alexithymia. Further-
more, the same study showed that anxiety and depression
facilitated the onset of headache whereas, in some patients,
the persistence of the pain rendered the patient more vul-
nerable to the onset of psychiatric symptoms.
Patients with headache who abuse analgesic drugs have
an ambivalent attitude towards the drugs they take, similar
to what occurs in drug addiction. In fact, it was recently
proposed to frame MOH within the spectrum of addictive
disorders [8].
The hypothesis of a greater psychological vulnerability
of the patient with headache to daily hassles has been
consistently confirmed [9, 10]. This vulnerability is char-
acterized by
(a) ineffective coping styles (internal coping, social
avoidance and isolation, pessimism, poor perception
of event predictability or control), and
(b) reduced affective regulation ability, in particular
anger, towards which the patient with headache
shows excessive inhibition-repression and/or inward
directedness [9, 10].
In patients with chronic tension headache and facial
pain, Jacobson and Folstein [11] observed inadequate stress
coping mechanisms, along with major depression, panic
attacks and psychoactive substance abuse.
Wacogne et al. [12] found clinically significant anxiety,
as assessed through the Hospital Anxiety and Depression
Scale, and emotional distress, as assessed through the
Perceived Stress Questionnaire, in 141 patients with
migraine compared to 109 controls, thereby confirming the
role of stress as a trigger.
However, the higher stress vulnerability hypothesis of
headache is not always confirmed. Peripheral stress
markers may not correlate with stress in patients with
headache and, despite the fact that many mechanisms may
be shared among different headache sufferers, different
headache subtypes may differ as to their stress vulnera-
bility [13–15].
In Greco-Roman medicine, temperaments were pro-
posed as constitutional emotional reactivity patterns
fashioned by the humoral theory [16, 17]. Kraepelin [18]
proposed four basic affective dispositions—depressive,
manic, irritable and cyclothymic—which he believed to be
subclinical forms of affective psychoses which had their
roots in adolescence. In line with these classic formula-
tions, and concordant with Kretschmer’s [19] views,
research by Akiskal and his colleagues [20, 21] formulated
criteria for temperaments which are relevant for mood
disorders conceptualized in a continuum, ranging from
subthreshold affective traits at one end to severe affective
psychosis at the other end [17, 22, 23]. In this framework,
five temperaments are proposed [24]: Depressive, Hyper-
thymic (borrowing this term from Schneider [25] to replace
the ‘manic’ type of Kraepelin), Cyclothymic, Irritable and
Generalized Anxious; the latter represents an addition
beyond the classic German concepts [26]. However, it
remains unresolved whether the Irritable temperament is
merely a subtype of the Cyclothymic temperament or
whether it stands on its own [26, 27]. In addition, the
placement of the anxious subtype within the classical
temperaments remains to be confirmed by empirical data.
Investigating the affective temperament profiles of 150
nonviolent suicide attempters (121 of whom had a current
major depressive episode) and 717 healthy controls, recent
findings showed that the suicide attempters scored signifi-
cantly higher on the four of the five affective temperaments
(depressive, cyclothymic, irritable and anxious) [28].
The aim of the present study was to evaluate the rela-
tionship between the quality of life, temperament, illness
perception, and mental turmoil in patients affected by
chronic headache. Mental turmoil is inversely related to
emotional well-being, a measure of ‘‘good life’’ as the
individual views it. In the present study, mental turmoil
was assessed using measures of depression and hopeless-
ness. Suicidal intent was measured both with the specific
section of the Mini-International Neuropsychiatric Inter-
view (MINI), a DSM-IV-TR based, short, structured
interview [29], and with the suicide score scale (SSS).
Methods
Study site and participants
Participants were 116 consecutive adult outpatients (102
women and 14 men) interviewed for clinical variables,
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admitted to the Regional Referral Headache Centre,
Department of Medical Sciences, Sant’Andrea Hospital in
Rome between January 2007–December 2007. Inclusion
criteria were a diagnosis of CDH (illness duration
[5 years) with concomitant MOH, and an age C 18 years.
Exclusion criteria were comorbidity with major disorders
of the central nervous system (e.g., Parkinson’s disease,
dementia, epilepsy), delirium and any condition affecting
the patient’s ability to complete the assessment, including
refusal of informed consent. The average age of the par-
ticipants was 48.11 years (SD = 12.03).
Participants participated voluntarily in the study, and
each subject provided written informed consent. The study
protocol received ethics approval from the local research
ethics review board.
Data collection and measurements
Patients were administered the Temperament Evaluation of
Memphis, Pisa, Paris and San Diego-autoquestionnaire
version (TEMPS-A), the Beck Hopelessness Scale (BHS),
the Hamilton Rating Scale for Depression (HAM-D) [30,
31], the MINI, the Revised Illness Perception Question-
naire (IPQ) [32], the SSS, and the Quality of Life Index
(QL-Index) [33].
The TEMPS-A is a self-rating questionnaire composed
of 109 items for men and 110 for women. The scoring of
the items produces five scores for affective temperaments:
Dysthymic, Cyclothymic, Anxious, Irritable and Hyper-
thymic. The Italian validation study of the TEMPS-A [34]
indicated a 3-factor solution: a large factor representing the
Dysthymic, Cyclothymic, and Anxious traits (Dys-Cyc-
Anx); the second and third factor replicated the original
Irritable and the Hyperthymic temperaments. Cronbach
Alpha coefficients for the three subscales were, respec-
tively, 0.89, 0.77 and 0.74.
The BHS is a 20-item scale for measuring the cognitive
component of the syndrome of depression. Hopelessness is
a cognitive trait considered to be associated with suicide,
leading suicidal patients to believe that suicide is the only
feasible strategy for dealing with their seemingly insoluble
problems. Empirical research has indicated a relationship
between hopelessness and suicidal intent [35–37]. Beck
et al. [38, 39] carried out two prospective studies of inpa-
tient and outpatient samples. The authors found that
hopelessness scores were related significantly to eventual
completed suicide. A cut-off score of 9 or above identified
most of the patients who eventually committed suicide.
The high-risk group identified in the latter study was 11
times more likely to commit suicide than the rest of the
outpatients. Thus, hopelessness may be used as an indicator
of suicide potential. Italian validation of the Beck Hope-
lessness Scale was provided by Pompili et al. [40] which
confirmed the existence of a strong association between
hopelessness and suicide risk.
The HAM-D is a 21-item scale rating the severity of
depressive symptoms during the previous 7 days. The scale
assesses autonomic, vegetative and psychological symp-
toms of depression. Studies have reported adequate
convergent validity and internal reliability [41]. A cut-off
of 15 or above is associated with moderate to severe
depression.
The MINI was used to evaluate suicide intent. The
section assessing the suicide intent evaluates the past and
current suicide behaviour and ideation and classifies sub-
jects into four groups: no suicidal risk, low suicidal risk,
moderate suicidal risk, and high suicidal risk. For the
present study, we grouped subjects into two groups: lower
suicidal intent (no suicidal intent and low suicidal intent)
and higher suicidal intent (moderate suicidal intent and
high suicidal intent).
The SSS consists of two sections, assessing suicide
ideation and behaviour in the last 12 months and lifetime
excluding the last year. Both sections consisted of six true-
false items: ‘‘Feel tired of living’’ (item 1), ‘‘Think that for
you, for your family and friends, it would better to be
dead’’ (item 2), ‘‘Think about physically hurting yourself’’
(item 3), ‘‘Think about taking your own life’’ (item 4),
‘‘Have planned a way of taking your own life’’ (item 5),
and ‘‘Have tried to take your own life’’ (item 6). Although,
the Suicide Score Scale has not yet been fully evaluated, it
has been previously administered to 851 Italian under-
graduate students with good internal consistency
(Cronbach alpha 0.87 and an inter-item mean correlation of
0.35) and moderate convergent validity with measures
assessing depression, reasons for living and aggression
(Reasons for Living total score: r = -0.32; P \ 0.001;
Zung Depression Scale: r = -0.41; P \ 0.001; Aggres-
sion Questionnaire: r = -0.53; P \ 0.001).
The IPQ measures patients’ illness perceptions. It has
demonstrated good reliability and validity across several
illness groups. The IPQ includes eight dimensions. Illness
identity measures the number of commonly experienced
symptoms such as pain, nausea, and upset stomach that the
patient associates with his/her particular illness. Conse-
quences measures patients’ beliefs about the seriousness of
their condition. Timeline is divided into an acute/chronic
subscale and a cyclical subscale that assesses whether
patients see their illness as cyclical in nature. The control
dimension is divided into personal control, which refers to
beliefs about one’s own ability to control symptoms, and
treatment control, which refers to a belief that treatment is
an effective way of controlling the illness. The illness
coherence subscale measures the degree to which patients
feel they have a coherent understanding or model of their
condition. Finally, the items of the causal dimension can be
J Headache Pain (2008) 9:349–357 351
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divided into four main subscales: psychological attribu-
tions that include items such as stress and overwork, risk
attributions that include factors such as diet and heredity,
immune attributions that include factors such as a virus and
the immune system, and chance attributions such as an
accident or bad luck.
The QL-index is a short self-administered scale evalu-
ating five aspects of quality of life: activity, daily living,
health, support and outlook, with a choice of three possible
answers and with higher scores reflecting a better quality of
life.
Data analysis
Pearson’s correlations were calculated to test the relation-
ship among quality of life, illness perception, temperament,
and mental turmoil scores. Hierarchical multivariate
regression analysis was performed to test multivariate
associations among the variables.
All statistical analyses were performed using the SPSS
13.0 statistical software package.
Results
Summary statistics are listed in Table 1. Twenty-eight
percent of the CDH plus MOH patients had a score on the
HAM-D of 15 or above indicating a moderate to severe
depression; 35% reported a BHS score of 9 or above
indicating severe hopelessness, and around 8% were eval-
uated with moderate to severe suicide intent on the MINI.
Thus, one out of three patients reported clinically relevant
symptoms of depression and hopelessness, although the
incidence of patients considered being at risk of suicide
was low.
Pearson’s correlations between the variables are shown
in Table 2. The results indicate that quality of life, tem-
perament, illness perception, and psychological turmoil are
associated. Quality of life is significantly associated with
TEMPS Dys-Cyc-Anx (r = -0.27; P \ 0.05), depression
(r = -0.61; P \ 0.01), hopelessness (r = -0.34;
P \ 0.01), SSS scores (Part 1: r = -0.47; P \ 0.01.
Part 2: r = -0.32; P \ 0.01. Total score: r = -0.41;
P \ 0.01), and the symptoms (r = -0.29; P \ 0.05) and
emotional representation (r = -0.34; P \ 0.01) dimen-
sions of the IPQ. Temperament was associated with several
illness perception dimensions: hyperthymic temperament
was inversely related to consequence (r = -0.28;
P \ 0.01) and directly related to personal control
(r = 0.27; P \ 0.01); irritability was associated with
timeline acute/chronic (r = 0.21; P \ 0.05) and with
emotional representation (r = 0.28; P \ 0.01); Dys-Cyc-
Anx was related to symptoms (r = 0.40; P \ 0.01),
timeline acute/chronic (r = 0.21; P \ 0.01), consequence
(r = .28; P \ 0.01) and emotional representation
(r = 0.43; P \ 0.01).
When evaluating the relationship between mental tur-
moil and illness perception, 18 of the 40 correlations were
statistically significant (see Table 2). Thus, patients with
higher mental turmoil have lower quality of life, with the
strongest effect for depression and suicidal intent as mea-
sured via the SSS.
Multivariate analysis
To evaluate multivariate associations among variables, we
performed a hierarchical multivariate regression analysis
with quality of life as dependent variable (see Table 3).
The analysis indicated that only the model with the mental
turmoil variables fits data (Model 4: adjusted R2 = 0.36;
R2 Change = 0.36; F change = 5.98 [df: 5,35], P \ 0.01;
F = 2.67 [df: 18,35], P \ 0.01). Models with sociodemo-
graphic variables (Model 1: adjusted R2 = -0.01; R2
change = 0.02; F change = 0.64 [df: 2,51], P = 0.53;
F = 0.64 [df: 2,51], P = 0.53), illness perception dimen-
sions (Model 2: adjusted R2 = -0.03; R2 change = 0.14;
Table 1 Descriptive statistics
Variables Mean Standard deviation





HAM-D [ 15, N (%) 33 (28.4)
BHS 7.36 4.75
BHS [ 9, N (%) 40 (34.6)
MINI suicide intent 10 (8.6)
SSS part 1 0.13 0.25
SSS part 2 0.18 0.28







Timeline acute/chronic 0.46 0.17
Timeline cyclical/episodic 0.54 0.23
Consequences 0.43 0.15
Personal control 0.32 0.12
Treatment control 0.48 0.12
Illness coherence 0.47 0.18
Emotional representation 0.39 0.16
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F change = 0.93 [df: 8,43], P = 0.50; F = 0.87 [df:
10,43], P = 0.57), and temperament dimensions (Model 3:
adjusted R2 = -0.04; R2 change = 0.05; F change = 0.85
[df: 3,40], P = 0.47; F = 0.86 [df: 13,40], P = 0.60)
failed to produce good fit. Only one variable was associated
with quality of life: the MINI suicidal intent (standardized
regression coefficient = -0.55; t = -3.06; P \ 0.01).
Finally, we computed a model with only this one signifi-
cant variable. This model explained 31% of the variability
of the QL-Index (Final model: adjusted R2 = 0.31; R2
change = 0.32; F = 38.29 [df: 1,82], P \ 0.01). Thus,
when controlling for the presence of other variables, only
mental turmoil was significantly associated with the quality
of life.
Discussion
The aim of the present study was to investigate the quality
of life, temperament, suicide risk and depression in patients
suffering from CDH with MOH. We found that suicide risk
played a central role in affecting the quality of life of the
patients in this study. The study also reported the first
evidence regarding temperament in patients suffering from
chronic daily headache with MOH.
Suicide is one of the world’s largest public health
problems, accounting for approximately 1 million lives lost
annually. This represents a global mortality rate of 16 per
100,00, or one death every 40 seconds. As one of the
leading causes of death worldwide, particularly in younger
Table 3 Multivariate association among variables











Age -0.15NS -0.10NS -0.14NS -0.09NS
Sex 0.03NS 0.13NS 0.14NS 0.16NS







Consequences -0.14NS -0.10NS 0.14NS
Personal control -0.13NS -0.17NS -0.18NS
Treatment control 0.11NS 0.12NS -0.02NS












SSS part 1 -0.17NS




Models indeces step Adjusted R2 R2 change F change df1, df2 P F df1/df2 P
1 -0.01 0.02 0.64 2,51 \0.53 0.64 2,51 \0.53
2 -0.03 0.14 0.93 8,43 \0.50 0.87 10,43 \0.57
3 -0.04 0.05 0.85 3,40 \0.47 0.86 13,40 \0.60
4 0.36 0.36 5.98 5,35 \0.01 2.67 18,35 \0.01
Final 0.31 0.32 38.29 1,82 \0.01 38.29 1,82 \0.01
NS not significant;  significant at P \ 0.01
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people, it profoundly affects individuals, families, work-
places, neighbourhoods and societies. The economic costs
associated with suicide and self-inflicted injuries are esti-
mated to be in billions of dollars [42]. According to the
World Health Organization, suicide is a huge but pre-
ventable public health problem [42].
Likewise, CDH is a source of great distress, with
impairment of pleasure and working activities. Decreased
quality of life can result in hopelessness and despair, and
suicidal wishes can easily emerge. Of some importance is
the close similarity between headache and mental turmoil.
Both refer to pain, in the head and in the psyche, respec-
tively. However, this symbolic association may have a
basis in reality. Although Shneidman [43] admitted that
each suicide is a multifaceted event, that biological, cul-
tural, sociological, interpersonal, intrapsychic, logical,
philosophical, conscious and unconscious elements are
always present, he suggested that the essential nature of
suicide is psychological, meaning that each suicidal drama
occurs in the mind of a unique individual. It is widely
acknowledged in suicidology that suicidal individuals are
experiencing psychological pain or suffering and that sui-
cide may be, at least in part, an attempt to escape from this
suffering.
Shneidman [44, 45] coined the term ‘‘psychache’’ to
describe this pain. Psychache is the hurt, anguish, or ache
that takes hold of the mind, the pain of excessively felt
shame, guilt, fear, anxiety, loneliness, angst and dread of
growing old or of dying badly. Suicide is functional
because it abolishes the pain for the individual. Suicide
occurs when the psychache is deemed by that individual to
be unbearable. It is an escape from intolerable suffering.
One may wonder if this assumption is valid also for chronic
daily headache and that suicide risk may increase when
physical pain is higher than a given individual’s threshold.
Although both CDH and depression seem to function as
obstacles in the lives of those that are affected by them,
they do not have any other outwardly symptoms in com-
mon. Many clinical studies, however, have noted the
degree to which chronic daily headache seemed to be
comorbid with other anxiety and affective disorders. It
seems that this association of migraines with other types of
disorders is important because, if the association is strong
enough, the proper types of treatment available will have to
be tested for their effects on the other comorbid condition.
For example, CDH can be treated with many different
types of drugs, and so for someone who experiences CDH
and has also been diagnosed with Major Depressive Dis-
order (MDD), it would be important to avoid drug
treatments, such as beta-blockers, which produce side
effects such as drowsiness, fatigue, lethargy, sleep disor-
ders, nightmares, depression, memory disturbance, and
hallucinations [46]. This would run the risk of increasing
the severity of the depressive symptoms. Instead, tricyclic
antidepressants (TCAs) should be used, which would treat
both the migraine and the depression.
There have been studies to see if this link between CDH
and anxiety/affective disorders was substantial and to
determine its cause. Breslau, Merikangas, and Bowden [47]
thought that it would be important to first make sure that
this link could actually be found in a population-based
study. In fact, it seemed possible that the association
between migraines and these various disorders in a clinical
setting might be simply due to the possibility that patients
suffering from multiple disorders might be more inclined to
seek treatment. If this were true, then a population-based
study would find much less of an association than would a
clinical-based study. However, the results of the popula-
tion-based study showed that the association was in fact
genuine.
In these research papers, the term mood disorder was
considered interchangeable with the term affective disor-
der. The main types of affective disorders that were
examined were major depression, dysthymia, bipolar dis-
order and cyclothymia. Dysthymia is a type of chronic
depressed or irritable mood disorder, and cyclothymia is a
mild form of bipolar II disorder, characterized by major
depressive and hypomanic episodes. It was found that
dysthymia, MDD, manic episodes and bipolar spectrum
disorders were more common in those who also experi-
enced migraines than in those who did not. What was even
more interesting, is that they discovered that there is a
difference in the extent of comorbidity of migraine and
affective disorders between those who experienced
migraine with aura and those who experienced migraine
without aura. Migraine patients with aura seemed to have a
higher prevalence of each of the affective disorders. Spe-
cifically, ‘‘major depression was by far the most common
affective disorder in persons with migraine with aura and
migraine without aura’’ [47]. The next step was to try and
explain this strong probability of coexistence. Two possible
explanations were that (1) one condition might be causing
the other, or (2) they might share genetic or environmental
etiological factors. For example, it seems plausible that the
extreme pain experienced during a migraine might cause
one to feel completely powerless over one’s own life, and
thus feel depressed. To test if this was the cause of the
association between migraine and depression, people were
seen once and then again three and a half years later. The
result showed that there is both a relative risk of developing
MDD after experiencing migraine and of developing
migraine after experiencing MDD. This makes the previ-
ously stated hypothesis about migraine causing depressive
symptoms seem less plausible, since MDD also raises the
risk of developing migraine. Thus there must be some other
explanation for their comorbid association.
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Next, families were studied to see if the association
between migraine and depression was transmitted, indi-
cating genetic factors. However, it was found that there
was little cross-transmission of the pure forms of the two
disorders. If the association between the two disorders was
causal, then relatives of a family member with migraine,
for example, should have a higher probability of develop-
ing MDD only if he/she also had migraines. The test results
in this specific study did confirm this type of association.
There were no significant findings indicating a relative of
someone with migraine developing MDD without also
having migraine.
Some earlier experiments on the association between
migraine and various psychiatric disorders investigated
their relationship to suicidal thoughts and actions. Breslau
and Davis [48] reported that people with migraine had a
higher lifetime rate of suicide attempts than those with no
history of migraine. In addition, those with MDD and
migraine had a higher rate of suicide attempts than those
with only Major Depressive Disorder (MDD): 31.8 and
16.5%, respectively. This association of suicide attempts
with migraine was found to be specific to migraine with
aura. Breslau [49] found that the association of migraine
with aura and suicide attempt was not necessarily due to a
coexisting MDD. It may at first seem strange to discuss
suicidal attempts outside of the realm of MDD, but it was
stated in this paper that risk factors for suicide attempts,
outside of MDD, can include heavy use of alcohol and
other psychoactive substances, as well as a family history
of suicidal behaviours. Thus, it was stated that migraine
with aura alone was associated with significantly high rates
of suicidal tendencies, and that the risks of suicidal incli-
nations associated with migraine with aura and MDD was
much higher than that for those with only MDD. It was
proposed that serotonin abnormalities might be the one
factor that MDD, suicide and migraine all have in common,
and that this would explain the associations of migraine
with aura to suicide, because migraine with aura has been
found to be accompanied by more pronounced serotonin
imbalances than migraine without aura.
Abbate-Daga et al. [50] found that patients suffering
from migraine show more depressive symptoms, difficult
anger management with a tendency to hypercontrol, and a
distinctive personality profile with high harm avoidance,
high persistence and low self-directedness. When a logistic
regression was performed, the only significant predictors of
migraine were temperament variables. Their results suggest
that the personality traits and the psychosomatic mecha-
nisms of migraine patients may make them vulnerable to
stress and less skilled in coping with pain. These traits
correlate with dysregulated neurotransmitter systems which
may also be part of the psychobiological components of
personality, depressive disorders and migraine itself.
Sa´nchez-Roma´n et al. [51] investigated the personality
profile of a sample of Mexican patients with migraine using
the Temperament and Character Inventory (TCI). They
used two healthy control groups and a third group of non-
migraine pain controls. One hundred and forty two subjects
with migraine, 108 healthy blood donors, 269 young
healthy controls and 30 patients with non-migraine pain
(NMP) were included in the study. They found that patients
with chronic pain share some of the personality features of
patients with migraine, but their TCI profile could be
indicative of cluster C avoidant personality. Blood donors
were shown to have more energy, with a tendency to help
other people and be more optimistic. The results support
serotoninergic involvement as explaining the physiopa-
thology of migraine.
The strength of the present study is the systematic
clinical interviews for clinical data and the use of widely
used and validated psychometric instruments. There are
limitations to the generalization of the present results. First,
the relatively small sample sizes may affect the replica-
bility of results. Second, although we investigated
psychiatric variables, we did not make specific diagnoses.
Of note, for instance, is the fact that the Hamilton
Depression Rating Scale is not a tool for diagnosing
depression but rather to determine a depressive dimension.
In conclusion, we stress the need to assess suicide risk
carefully in patients suffering from CDH and MOH.
Obviously, more work is required in this area and future
research should aim to compare groups with different
forms of headache.
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